SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 26th, 2018 • Cure Pharmaceutical Holding Corp. • Plastics, foil & coated paper bags • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February __, 2018, among CURE Pharmaceutical Holding Corp., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT CURE PHARMACEUTICAL HOLDING CORPSecurity Agreement • March 26th, 2018 • Cure Pharmaceutical Holding Corp. • Plastics, foil & coated paper bags • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received [*] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated as of February [*], 2018, by and among CURE Pharmaceutical Holding Corp , a Nevada corporation (the “Company”) and the Holders signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms (the “Purchase Agreement”), at any time on or after the Original Issue Date and on or prior to the close of business on the third anniversary of the Original Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from the Company, subject to adjustment as set forth in Section 3 herein, up to a number of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) equal to fifty percent (50%) of the number of shares of Common Stock
